Journey Medical Corporation - Common Stock — Quarterly Financial Statistics (NASDAQ:DERM) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -2.83 M-942 K-2.38 M-6.28 M2.91 M -6.7 M Cash from investing activities -17 K-26 K-26 K-25 K-26 K -103 K Cash from financing activities 3.6 M165 K7.04 M5.43 M220 K 12.85 M Free cash flow -2.83 M-942 K-2.38 M-6.28 M2.91 M -6.7 M

News

Merck KGaA (MKKGY) Soars 5.3%: Is Further Upside Left in the Stock?

Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends? (FBIO)

Here's What Key Metrics Tell Us About Journey Medical (DERM) Q1 Earnings

Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates

Aurinia Pharmaceuticals (AUPH) Q1 Earnings and Revenues Top Estimates

Zevra Therapeutics (ZVRA) Q1 Earnings and Revenues Surpass Estimates

Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should Know

Assertio (ASRT) Moves 17.0% Higher: Will This Strength Last?

Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript

B.Riley reiterates Buy rating on Journey Medical stock, maintains $12 target

Journey Medical Stock: Emrosi Is Winning, But The Stock Hasn't Noticed (NASDAQ:DERM)

Minocycline study shows no microbiome disruption after 16-week use